We are live on ! Find out more
ARMP icon

Armata Pharmaceuticals

6.79 USD
-0.12
1.74%
At close Updated Jun 16, 4:00 PM EDT
Pre-market
After hours
6.79
0.00
0%
1 day
-1.74%
5 days
-14.59%
1 month
-10.66%
3 months
-29.93%
6 months
18.71%
Year to date
3.51%
1 year
269.02%
5 years
61.67%
10 years
-97.29%
 

About: Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.

Employees: 61

0
Funds holding %
of 8,096 funds
Positive news %
Price charts implemented using Lightweight Charts™